Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302156PMID 14712302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The murine alpha(1)-proteinase inhibitor gene family: polymorphism, chromosomal location, and structure.

  2002cited by this paper
• Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation.

  2002cited by this paper
• The murine α1-Proteinase inhibitor gene family: Polymorphism, chromosomal location, and structure

  2002cited by this paper
• Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

  2001cited by this paper
• Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

  2001cited by this paper
• Alpha-1-Antitrypsin and a Broad Spectrum Metalloprotease Inhibitor, RS113456, Have Similar Acute Anti-Inflammatory Effects

  2001cited by this paper
• Therapeutic elastase inhibition by alpha-1-antitrypsin gene transfer limits neointima formation in normal rabbits.

  2001cited by this paper
• Effect Of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle

  2001cited by this paper
• Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin.

  2000cited by this paper
• Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.

  2000cited by this paper
• Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis.

  1999cited by this paper
• Chain Length of the Polylysine in Receptor-targeted Gene Transfer Complexes Affects Duration of Reporter Gene Expression Both in Vitro and in Vivo *

  1999cited by this paper
• The NOD mouse model of type 1 diabetes: As good as it gets?

  1999cited by this paper
• Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint.

  1999cited by this paper
• Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes.

  1998cited by this paper
• Local control of alpha1-proteinase inhibitor levels: regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines.

  1998cited by this paper
• Local control of α1-proteinase inhibitor levels: regulation of α1-proteinase inhibitor in the human cornea by growth factors and cytokines

  1998cited by this paper
• Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.

  1998cited by this paper
• Binding of SPAAT, the 44‐residue C‐terminal peptide of α1‐antitrypsin, to proteins of the extracellular matrix

  1997cited by this paper
• Human colon carcinoma cells synthesize and secrete alpha 1-proteinase inhibitor.

  1996cited by this paper
• Human Colon Carcinoma Cells Synthesize and Secrete α1-Proteinase Inhibitor

  1996cited by this paper
• SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation.

  1993cited by this paper
• The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes.

  1991cited by this paper
• The SEC receptor recognizes a pentapeptide neodomain of α1-antitrypsin-protease complexes

  1991cited by this paper
• Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes.

  1990cited by this paper
• Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells.

  1989cited by this paper
• Distinct and additive effects of elastase and endotoxin on expression of alpha 1 proteinase inhibitor in mononuclear phagocytes.

  1988cited by this paper
• Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

  1988cited by this paper
• T-Lymphocyte Clone Specific for Pancreatic Islet Antigen

  1988cited by this paper
• Autoimmune Diabetes in NOD Mouse Is L3T4 T-Lymphocyte Dependent

  1987cited by this paper
• Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts.

  1987cited by this paper
• Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells

  1987cited by this paper
• Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells

  1986cited by this paper
• Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages.

  1985cited by this paper
• Structure and variation of human α1–antitrypsin

  1982cited by this paper
• Morphological identification of alpha‐I‐antitrypsin in the human small intestine

  1982cited by this paper
• Alpha-1-antitrypsin immunoreactivity in islet cells of adult human pancreas

  1977cited by this paper
• Alpha-l-Antitrypsin Immunoreactivity in Islet Cells of Adult Human Pancreas

  1977cited by this paper
• The Current Status of α-1-Antitrypsin, a Protease Inhibitor, in Gastrointestinal Disease

  1976cited by this paper
• The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.

  1976cited by this paper
• Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.

  1975cited by this paper

• Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy

  2025cites this paper
• a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm

  2025cites this paper
• The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways

  2025cites this paper
• Alpha 1-antitrypsin mitigates salt-sensitive hypertension in juvenile mice by reducing diacylglycerol concentrations and protein kinase C activity in kidney membranes

  2025cites this paper
• Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

  2024cites this paper
• Cell Therapies and Gene Therapy for Diabetes: Current Progress.

  2024cites this paper
• Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice

  2023cites this paper
• Viral vectors engineered for gene therapy.

  2023cites this paper
• Alpha-1 antitrypsin: a novel biomarker and potential therapeutic approach for metabolic diseases.

  2022cites this paper
• Novel insights into the relationship between α-1 anti-trypsin with the pathological development of cardio-metabolic disorders.

  2022cites this paper
• Human Alpha-1 Antitrypsin Attenuates ENaC and MARCKS and Lowers Blood Pressure in Hypertensive Diabetic db/db Mice

  2022cites this paper
• The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes

  2022cites this paper
• Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects.

  2022cites this paper
• Therapeutic Approaches for the Management of Autoimmune Disorders via Gene Therapy: Prospects, Challenges, and Opportunities.

  2021cites this paper
• Applications of Microfluidic Devices in the Diagnosis and Treatment of Cancer: A Review Study

  2021cites this paper
• Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus

  2021cites this paper
• Transgenic Mice Overexpressing Human Alpha-1 Antitrypsin Exhibit Low Blood Pressure and Altered Epithelial Transport Mechanisms in the Inactive and Active Cycles

  2021cites this paper
• Rattle-Structured Rough Nanocapsules with in Situ-Formed Gold Nanorod Cores for Complementary Gene/Chemo/Photothermal Therapy

  2021cites this paper
• Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin

  2020cites this paper
• Human plasma‐derived alpha1‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study

  2020cites this paper
• In vivo gene delivery mediated by non-viral vectors for cancer therapy

  2020cites this paper
• The Unusual Properties of the AAV Inverted Terminal Repeat

  2020cites this paper
• Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity

  2019cites this paper
• Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes

  2019cites this paper
• Alpha-1-Antitrypsin Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice

  2019cites this paper
• Glycated Whey Proteins Protect NOD Mice against Type 1 Diabetes by Increasing Anti-Inflammatory Responses and Decreasing Autoreactivity to Self-Antigens.

  2019cites this paper
• Alpha-1 Antitrypsin Therapy for Autoimmune Disorders.

  2018cites this paper
• Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes

  2018cites this paper
• Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV).

  2018cites this paper
• Gene therapy and type 1 diabetes mellitus.

  2018cites this paper
• Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice

  2018cites this paper
• Transplantation of Adipose Tissue–Derived Mesenchymal Stem Cell (ATMSC) Expressing Alpha-1 Antitrypsin Reduces Bone Loss in Ovariectomized Osteoporosis Mice

  2017cites this paper
• α-1 Antitrypsin Inhibits RANKL-induced Osteoclast Formation and Functions

  2017cites this paper
• Novel Biological Functions of A1AT

  2017cites this paper
• Two single nucleotide polymorphisms sites in α1-AT gene and their association with somatic cell score in Chinese Holstein cows

  2017cites this paper
• Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus

  2016cites this paper
• Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.

  2016cites this paper
• Alpha-1 Antitrypsin Gene Therapy Ameliorates Bone Loss in Ovariectomy-Induced Osteoporosis Mouse Model

  2016cites this paper
• Alpha-1 antitrypsin: Associated diseases and therapeutic uses.

  2016cites this paper
• Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery.

  2016cites this paper
• Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency

  2015cites this paper
• Acute‐phase protein α1‐anti‐trypsin: diverting injurious innate and adaptive immune responses from non‐authentic threats

  2015cites this paper
• T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin

  2015cites this paper
• Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.

  2014cites this paper
• Immune-modulating effects of alpha-1 antitrypsin

  2014cites this paper
• Mechanistic Evidence in Support of Alpha1-Antitrypsin as a Therapeutic Approach for Type 1 Diabetes

  2014cites this paper
• Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With β-Cell Autoimmunity in Patients With Type 1 Diabetes

  2014cites this paper
• The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity

  2014cites this paper
• Effect of Recombinant α1-Antitrypsin Fc-Fused (AAT-Fc) Protein on the Inhibition of Inflammatory Cytokine Production and Streptozotocin-Induced Diabetes

  2013cites this paper
• Bergin Degranulation and Autoimmunity-1 Antitrypsin Regulates Neutrophil α The Circulating Proteinase Inhibitor

  2013cites this paper
• Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.

  2013cites this paper
• Pancreatic Islet Xenograft Survival in Mice Is Extended by a Combination of Alpha-1-Antitrypsin and Single-Dose Anti-CD4/CD8 Therapy

  2013cites this paper
• Par-4 as a potential target for cancer therapy

  2013cites this paper
• Novel Therapeutic Uses of Alpha-1 Antitrypsin: A Window to the Future

  2012cites this paper
• Transgene therapy for rat anti-Thy1.1 glomerulonephritis via mesangial cell vector with a polyethylenimine/decorin nanocomplex

  2012cites this paper
• Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent

  2012cites this paper
• α-1-Antitrypsin and IFN-γ reduce the severity of IC-mediated vasculitis by regulation of leukocyte recruitment in vivo.

  2012cites this paper
• Expanding the Clinical Indications for α1-Antitrypsin Therapy

  2012cites this paper
• Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model

  2011cites this paper
• α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection

  2011cites this paper
• Diabetes IL-2 Gene Therapy Prevents Autoimmune Inducible Adeno-Associated Virus-Mediated

  2011cites this paper
• WITHDRAWN: Potential link between alpha 1 anti-trypsin and PAR-2 in the prevention of beta cell dysfunction(☆).

  2011cites this paper
• Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.

  2011cites this paper
• Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy

  2011cites this paper
• Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes

  2011cites this paper
• Inducible Adeno-Associated Virus-Mediated IL-2 Gene Therapy Prevents Autoimmune Diabetes

  2011cites this paper
• In vivo and in vitro protective effects of alpha-1 antitrypsin on doxorubicin-induced cytotoxicity

  2011cites this paper
• Combination of alpha‐1 antitrypsin and doxycycline suppresses collagen‐induced arthritis

  2010cites this paper
• α 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells

  2010cites this paper
• Development of AAV vectors for the therapy of autoimmune and inflammatory diseases

  2010cites this paper
• New Strategies in Drug Development Focusing on the Anti-Protease- Protease Balance in Alpha-1 Antitrypsin Deficiency

  2010cites this paper
• Lung disease associated with alpha1-antitrypsin deficiency.

  2010cites this paper
• Intradermal α1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease

  2010cites this paper
• Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine.

  2009cites this paper
• Evolution and cellular biology of the uterine serpins

  2009cites this paper
• Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes

  2009cites this paper
• Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors

  2009cites this paper
• Angiostatic factors normally restrict islet endothelial cell proliferation and migration: implications for islet transplantation

  2009cites this paper
• Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.

  2009cites this paper
• Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts.

  2008cites this paper
• Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity.

  2008cites this paper
• Novel thermoresponsive nonviral gene vector: P(NIPAAm-co-NDAPM)-b-PEI with adjustable gene transfection efficiency.

  2008cites this paper
• Characterization of Pleiotropic Activities of alpha1-Antitrypsin

  2008cites this paper
• Characterization of Pleiotropic Activities of α1-Antitrypsin

  2008cites this paper
• Reversal of overt type I diabetes in the NOD mouse through the use of combination therapy

  2008cites this paper
• Human alpha 1‐antitrypsin therapy induces fatal anaphylaxis in non‐obese diabetic mice

  2008cites this paper
• Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats

  2007cites this paper
• Allogeneic islet transplantation

  2007cites this paper
• Translational Mini‐Review Series on Type 1 Diabetes: Immune‐based therapeutic approaches for type 1 diabetes

  2007cites this paper
• α1-Antitrypsin Protects β-Cells From Apoptosis

  2007cites this paper
• Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin.

  2007cites this paper
• Molecular Multitasking in the Airspace

  2007cites this paper
• Genetic manipulation of the pancreas

  2007cites this paper
• Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice.

  2006cites this paper
• Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin‐induced diabetic rats

  2006cites this paper
• α 1-Antitrypsin Gene Therapy Modulates Cellular Immunity and Efficiently Prevents Type 1 Diabetes in Nonobese Diabetic Mice

  2006cites this paper
• Treatment of human disease by adeno-associated viral gene transfer

  2006cites this paper
• Stimulierung der Proliferation pankreatischer Beta-Zellen

  2006cites this paper
• Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno‐associated virus (rAAV1) vector

  2006cites this paper
• Stimulation de la prolifération des cellules pancréatiques bêta

  2006cites this paper